MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on December 29, 2004; DOI: 10.1124/mol.104.008268


0026-895X/05/6704-983-991$20.00
Mol Pharmacol 67:983-991, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
mol.104.008268v1
67/4/983    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Deraet, M.
Right arrow Articles by Maroteaux, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deraet, M.
Right arrow Articles by Maroteaux, L.
Accelerated Communication

The Natural Mutation Encoding a C Terminus-Truncated 5-Hydroxytryptamine2B Receptor Is a Gain of Proliferative Functions

Maud Deraet, Philippe Manivet, Agnes Janoshazi, Jacques Callebert, Silke Guenther, Ludovic Drouet, Jean-Marie Launay, and Luc Maroteaux

Institut de Génétique et de Biologie Moléculaire et Cellulaire, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Université L. Pasteur de Strasbourg, Illkirch, France (M.D., A.J., S.G., L.M.); and IFR6, Services de Biochimie et d'Angio-Hématologie, Hôpital Lariboisière, Paris, France (P.M., J.C., L.D., J.-M.L.)

Although potentially implicated in several physiological functions, few functional mutations have been identified in the human 5-hydroxytryptamine (HT)2B receptor gene. A heterozygous mutation R393X in the 5-HT2B receptor was recently identified in a patient diagnosed with pulmonary hypertension after intake of the anorexigenic dexfenfluramine. Although reported to generate a lack of function, this C terminus-truncated 5-HT2B receptor should somehow affect transduction pathways relevant to pulmonary hypertension. In our study, we investigated putative modifications in transduction of the R393X-mutated 5-HT2B receptor. In stably transfected cells, we confirmed the loss of inositol 1,4,5-trisphosphate stimulation caused by the G{alpha}q uncoupling, despite conserved ligand affinity between the normal and mutated receptors. We also observed a partial loss of nitric-oxide synthase stimulation. However, the truncated R393X receptor presented 1) a strong gain of efficacy in cell proliferation as assessed by mitogen-activated protein kinase activity and thymidine incorporation, 2) a preferential coupling to G{alpha}13 as shown by blocking antiserum, and 3) an apparent lack of internalization upon agonist stimulation as observed by confocal microscopy. This work demonstrates that, in the 5-HT2B receptor, the C terminus, including the palmitoylation and phosphorylation sites, is absolutely required for proper transduction and internalization. For the first time, we show that the lack of C terminus can generate a switch of coupling to G{alpha}13, a reduced NO synthase activation, and an increase in cell proliferation. All these modifications are relevant in pathophysiological vasoconstriction.


Received October 14, 2004; accepted December 28, 2004

Address correspondence to: Dr. Luc Maroteaux, INSERM U616 Hospital Pitié-Salpetrière, Batiment Pédiatrie, 47 bd de l'Hôpital, 75651 Paris Cedex 13, France. E-mail: luc.maroteaux{at}chups.jussieu.fr




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
A. Janoshazi, M. Deraet, J. Callebert, V. Setola, S. Guenther, B. Saubamea, P. Manivet, J.-M. Launay, and L. Maroteaux
Modified Receptor Internalization upon Coexpression of 5-HT1B Receptor and 5-HT2B Receptors
Mol. Pharmacol., June 1, 2007; 71(6): 1463 - 1474.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Callebert, J. M. Esteve, P. Herve, K. Peoc'h, C. Tournois, L. Drouet, J. M. Launay, and L. Maroteaux
Evidence for a Control of Plasma Serotonin Levels by 5-Hydroxytryptamine2B Receptors in Mice
J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 724 - 731.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics